Novo Nordisk A/S: all 1,444 studies

Page 7 of 15. Open to participants first (108), then studies with results posted, then the rest; newest registration first within each.

• A Study Investigating the Safety and Performance of DV3395, a New Concept Device for the Delivery of Medicine.CompletedNCT05314283Phase 1
• A Research Study Looking at Mim8 in Children With Haemophilia A With or Without InhibitorsCompletedNCT05306418Phase 3
• A Study to Explore the PK and PD of INV-202 in Metabolic SyndromeCompletedNCT05282446Phase 1
• A Study to Look at How Insulin NNC0471-0119 Works in the Body in People With Type 1 Diabetes When Injected by Insulin PumpCompletedNCT05262595Phase 1
• A Research Study of How NNC0174-0833 Behaves in Chinese Volunteers Who Are Normal Weight, Overweight or With ObesityCompletedNCT05254158Phase 1
• Awareness, Care & Treatment In Obesity Management - An Observation in Asia PacificCompletedNCT05250427
• Vaginal Estradiol Tablets (Vagifem®) and Endometrial Cancer Risk in the Treatment of Postmenopausal Vaginal AtrophyCompletedNCT05243823
• A Research Study Looking at How 50 mg Semaglutide Daily Affects Food Intake and Emptying of the Stomach in People With ObesityCompletedNCT05236517Phase 1
• Awareness, Care & Treatment In Obesity Management - An Observation in SwitzerlandCompletedNCT05232786
• A Clinical Trial Looking at the Comparability of 2 Different Forms of SemaglutideCompletedNCT05232708Phase 1
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Italy, as Part of Local Clinical PracticeCompletedNCT05230615
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Saudi Arabia, as Part of Local Clinical PracticeCompletedNCT05230589
• Post-Marketing Surveillance (Special Use-results Surveillance on Long-term Use) With Sogroya®Active, not recruitingNCT05230550
• A Research Study Looking at the Comparability of 2 Different Forms of Oral Semaglutide in Healthy PeopleCompletedNCT05227196Phase 1
• China Research of IDEgAsp Treatment in Real-world Clinical practicE (CREATE)CompletedNCT05221580
• A Study in Healthy Participants Investigating Biomarkers After Exposure to Heparin When Heparin is Administered in the Fasted State or After a High-fat Meal. Heparin, a Registered Drug, is an Anticoagulant (Blood Thinner) That Prevents the Formation of Blood Clots.CompletedNCT05178550Early Phase 1
• A Research Study About Weight Loss and Treatment Patterns With the Use of Saxenda® in Adults in Real-life Settings in SwitzerlandCompletedNCT05153590
• A Research Study Looking Into the Effect of Semaglutide and NNC0480 0389 on Blood Levels of a Birth Control Pill in Woman After MenopauseCompletedNCT05153564Phase 1
• An Extension Study of Belcesiran in Patients With Alpha-1 Antitrypsin Deficiency Associated Liver Disease (AATLD)WithdrawnNCT05146882Phase 2
• A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without InhibitorsActive, not recruitingNCT05135559Phase 3
• A Multiple Dose Study Investigating Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0363-0845 in Participants With Type 1 Diabetes Pharmacokinetics and Pharmacodynamics: How Insulin NNC0363-0845 is Transported Throughout the Body and How It WorksCompletedNCT05134987Phase 1
• A Research Study Looking at New Protein-based Tablets in Healthy Male ParticipantsCompletedNCT05129891Phase 1
• A Research Study of How a New Medicine NNC0365-3769 (Mim8) Works in the Body of Healthy PeopleCompletedNCT05127473Phase 1
• A Research Study Looking Into Levels of the Medicine NNC0385-0434 in the Body and How Well it is Tolerated in Participants With Impaired Kidney Function Compared to Participants With Normal Kidney FunctionTerminatedNCT05094934Phase 1
• A Research Study Looking at the Effect of Food Intake on How the Medicine NN0385-0434 Behaves in the Body of Healthy ParticipantsCompletedNCT05091073Phase 1
• A Research Study Looking at How the Use of NovoPen® 6 for Treatment With Tresiba® & Fiasp® Affects the Blood Sugar Level in Patients With Type 1 Diabetes as Part of Local Clinical PracticeCompletedNCT05069545
• A Research Study Investigating Mim8 in Adults and Adolescents With Haemophilia A With or Without InhibitorsCompletedNCT05053139Phase 3
• A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy PeopleCompletedNCT05046873Phase 1
• ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and InflammationCompletedNCT05021835Phase 3
• Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH)CompletedNCT05016882Phase 2
• A Research Study Looking Into Blood Levels of the Medicine NNC0480-0389 in Participants With Reduced Kidney Function Compared to Participants With Normal Kidney FunctionCompletedNCT05015894Phase 1
• Awareness, Care & Treatment In Obesity Management - An International Observation Among Teens (ACTION Teens)CompletedNCT05013359
• A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)CompletedNCT05013229Phase 3
• A Research Study Looking at How the Medicine NNC0385-0434 Works in the Body of Healthy Japanese MenCompletedNCT05003440Phase 1
• A Study of Etavopivat in Patients With Thalassemia or Sickle Cell DiseaseCompletedNCT04987489Phase 2
• SELECT-LIFE: A Research Study Looking at Long-term Effects of Semaglutide in People Who Took Part in the SELECT Cardiovascular Outcomes TrialCompletedNCT04972721
• Regulatory Post Marketing Surveillance (rPMS) Study of Xultophy® (Insulin Degludec/Liraglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in KoreaCompletedNCT04952779
• A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Combined Versus Separate Injections in People With Overweight or ObesityCompletedNCT04940078Phase 1
• Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 DiabetesCompletedNCT04916470Phase 3
• Investigating the Effect of Ryzodeg® in Adult Patients With Type 2 Diabetes in LebanonCompletedNCT04892069
• A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Japanese MenCompletedNCT04878406Phase 1
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Japan, as Part of Local Clinical PracticeCompletedNCT04878393
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in the United Kingdom, as Part of Local Clinical PracticeCompletedNCT04862923
• A Study to Test How a New Long-acting Insulin (Insulin Icodec) Works in the Body of People From China With Type 2 DiabetesCompletedNCT04857398Phase 1
• GOAL: A Research Study Looking at Long Term Blood Sugar Control in People With Type 2 Diabetes Treated With Xultophy® in Local Clinical Practice in Japan.CompletedNCT04838743
• Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)Active, not recruitingNCT04822181Phase 3
• A Research Study to See How Much Semaglutide and SNAC is in the Milk of Healthy, Breastfeeding Women Taking Semaglutide TabletsCompletedNCT04817644Phase 1
• Remote Study Collecting Blood Glucose Values and Activity Data in Patients With Type 2 Diabetes on Different TreatmentsCompletedNCT04809311
• A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)CompletedNCT04777409Phase 3
• A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)CompletedNCT04777396Phase 3
• SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With ObesityActive, not recruitingNCT04775082Phase 3
• A Research Study Looking at How the Medicine NNC0194-0499 Behaves in Japanese and Non-Asian MenCompletedNCT04722653Phase 1
• A Research Study to Look at How Faster Aspart Works in Chinese People With Type 1 Diabetes or Type 2 DiabetesCompletedNCT04698018Phase 1
• A Study Investigating the Distribution and Metabolism of Three 14C-labeled Radioactive Study CompoundsCompletedNCT04676906Phase 1
• A Research Study Looking at Long-term Blood Sugar Control in People With Type 2 Diabetes Being Treated With Xultophy® in a Real-world Setting in ItalyCompletedNCT04666987
• A Study Investigating the Clinical Parameters Associated With the Use of Ryzodeg® (Insulin Degludec/Insulin Aspart) in a Real-world Adult Population With Type 2 Diabetes in South KoreaCompletedNCT04656106
• A Study to Look at How Safe Insulin NNC0471-0119 is and How it Works in People With Type 1 Diabetes MellitusCompletedNCT04655690Phase 1
• A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS)Active, not recruitingNCT04624659Phase 3
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Sweden, as Part of Local Clinical PracticeCompletedNCT04601753
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical PracticeCompletedNCT04601740
• A Study to Test How a New Long-acting Insulin (Insulin Icodec) Works in the Body of People With Liver DiseaseCompletedNCT04597697Phase 1
• Turoctocog Alfa in Haemophilic Italian Patients: Protection and Engagement in Recreational ActivitiesCompletedNCT04584892
• A Study Looking at How Insulin Icodec is Taken up in the Blood When Administered in Different Injection Sites in People With Type 2 DiabetesCompletedNCT04582448Phase 1
• A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Insulin Icodec in Subjects With Type 2 DiabetesCompletedNCT04582435Phase 1
• A Study of FT-7051 in Men With MCRPCTerminatedNCT04575766Phase 1
• A Clinical Study to Compare the Efficacy and Safety of a Novel Medicine (NNC0268-0965) With Insulin GlargineCompletedNCT04575181Phase 1
• Epidemiological Assessment of the Risk for Pancreatic Cancer Associated With the Use of Semaglutide in Patients With Type 2 Diabetes - A Cohort Study Based on Nordic Registry DataCompletedNCT04572165
• A Study to Look at the Safety of NNC0363-0845 in Healthy People and People With Type 1 DiabetesCompletedNCT04569994Phase 1
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Canada, as Part of Local Clinical PracticeCompletedNCT04559815
• Study to Evaluate Safety, Tolerability, PK and PD of DCR-PHXC in PH Type 3 PatientsCompletedNCT04555486Phase 1
• Natural History of Patients With PH3 and a History of Stone EventsCompletedNCT04542590
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Denmark, as Part of Local Clinical PracticeCompletedNCT04537637
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Switzerland, as Part of Local Clinical PracticeCompletedNCT04537624
• Safety, Tolerability, and Pharmacokinetics of Single Ascending Oral Doses of INV-101 in Healthy Male and Female SubjectsCompletedNCT04531150Phase 1
• Research Study Comparing New Tablets of Semaglutide in New Doses, in Healthy PeopleCompletedNCT04524832Phase 1
• A Clinical Trial Comparing Semaglutide in Healthy People Who Eat and Take the Medicine at Different TimesCompletedNCT04513704Phase 1
• Injection Site Pain Comparison of Excipient SolutionsCompletedNCT04482725Phase 1
• Post-Marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ozempic®CompletedNCT04469855
• Clinical Outcomes of NovoSeven® Treatment in Severe Postpartum Haemorrhage - a Study at the University Hospital of BernCompletedNCT04444856
• Post-Marketing Surveillance (Use-results Surveillance) With Esperoct®CompletedNCT04334057
• A Research Study, Looking at How Tresiba® Works in People With Type 2 Diabetes in Local Clinical Practice in RussiaCompletedNCT04315688
• SUSTAIN SWITCH: A Research Study to Compare Two Dose Schedules of Semaglutide Taken Once Weekly in People With Type 2 DiabetesWithdrawnNCT04287179Phase 3
• A Study to Look at How Safe NNC0472-0147 is in Healthy People and in People With Type 2 DiabetesCompletedNCT04262661Phase 1
• A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice (SURE GERMANY)CompletedNCT04261933
• First Research Study to Look at How Two Medicines, NNC0480-0389 and Semaglutide, Work Together in Healthy People, in People With High Body Weight and in People With DiabetesCompletedNCT04259801Phase 1
• A Research Study to Compare Two Different Forms of Once-weekly Semaglutide in Two Different Injection PensCompletedNCT04238962Phase 1
• A Research Study Looking at the Comparability (Bioequivalence) of Two Versions of SemaglutideCompletedNCT04228354Phase 1
• A Research Study, Looking at How Tresiba® Works in People With Type 2 Diabetes in Local Clinical Practice in ChinaCompletedNCT04227431
• A Research Study Looking Into Blood Levels of NNC0174-0833 in People With Normal and Impaired Kidney FunctionCompletedNCT04209049Phase 1
• A Research Study Investigating Mim8 in People With Haemophilia ACompletedNCT04204408Phase 2
• A Research Study Looking at the Comparability (Bioequivalence) of Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or ObesityCompletedNCT04187300Phase 1
• Study of DCR-A1AT in Healthy Adult VolunteersCompletedNCT04174118Phase 1
• A Research Study Looking at Similarity Between Once-weekly Semaglutide Versions for Different Injection PensCompletedNCT04152915Phase 1
• A Study to Look at How Safe NNC0268-0965 is in People With Type 2 DiabetesCompletedNCT04136067Phase 1
• A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (C) Semaglutide TabletsCompletedNCT04109508Phase 1
• A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide TabletsCompletedNCT04097600Phase 1
• A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Italy, as Part of Local Clinical PracticeCompletedNCT04094415
• A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in France, as Part of Local Clinical Practice (SURE FRANCE)CompletedNCT04083820
• Research Study to Investigate the Effect of NNC0174-0833 on a Birth Control Pill in Women Who Are Not Able to Become PregnantCompletedNCT04074174Phase 1
• A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical PracticeCompletedNCT04067999

← Novo Nordisk A/S overview and focus areas